RHHBY
Price:
$38.41
Market Cap:
$212.41B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2003-08-20
Stock Exchange
PNK
Ticker
RHHBY
According to Roche Holding AG’s latest financial reports and current stock price. The company's current PE Ratio is 19.90. This represents a change of 40.24% compared to the average of 14.19 of the last 4 quarters.
The mean historical PE Ratio of Roche Holding AG over the last ten years is 21.32. The current 19.90 PE Ratio has changed 9.24% with respect to the historical average. Over the past ten years (40 quarters), RHHBY's PE Ratio was at its highest in in the September 2017 quarter at 33.77. The PE Ratio was at its lowest in in the June 2022 quarter at 7.55.
Average
21.32
Median
20.31
Minimum
16.93
Maximum
26.46
Discovering the peaks and valleys of Roche Holding AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.45%
Maximum Annual PE Ratio = 26.46
Minimum Annual Increase = -21.91%
Minimum Annual PE Ratio = 16.93
Year | PE Ratio | Change |
---|---|---|
2023 | 16.93 | -9.16% |
2022 | 18.64 | -18.96% |
2021 | 23.00 | 23.83% |
2020 | 18.58 | -6.89% |
2019 | 19.95 | 0.28% |
2018 | 19.90 | -18.61% |
2017 | 24.45 | 18.30% |
2016 | 20.66 | -21.91% |
2015 | 26.46 | 7.64% |
2014 | 24.58 | 29.45% |
The current PE Ratio of Roche Holding AG (RHHBY) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
19.53
5-year avg
19.42
10-year avg
21.32
Roche Holding AG’s PE Ratio is greater than Sanofi (16.00), less than AstraZeneca PLC (37.31), less than GSK plc (31.12), less than Merck & Co., Inc. (20.34), greater than Novartis AG (14.53), greater than Bristol-Myers Squibb Company (-16.36), less than Gilead Sciences, Inc. (102.01),
Company | PE Ratio | Market cap |
---|---|---|
16.00 | $138.25B | |
37.31 | $240.31B | |
31.12 | $82.07B | |
20.34 | $279.51B | |
14.53 | $226.25B | |
-16.36 | $107.05B | |
102.01 | $107.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roche Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Roche Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Roche Holding AG's PE Ratio?
How is the PE Ratio calculated for Roche Holding AG (RHHBY)?
What is the highest PE Ratio for Roche Holding AG (RHHBY)?
What is the 3-year average PE Ratio for Roche Holding AG (RHHBY)?
What is the 5-year average PE Ratio for Roche Holding AG (RHHBY)?
How does the current PE Ratio for Roche Holding AG (RHHBY) compare to its historical average?